GLP-1 drugs linked to 17% drop in worker sick leave, new economic study finds
A new study links GLP-1 drugs like Ozempic to a 17% drop in worker sick leave. Here's what…
Charles · Jul 29, 2026Machine Learning for Life Scientists: A Practical Methods Guide
Can biologists use machine learning without a CS degree? In 2026, yes — here's what methods actually work…
Charles · Jul 14, 2026Ice Spice: Depression Caused My Weight Loss, Not Ozempic
Ice Spice clarifies her weight loss was due to depression, not Ozempic, raising questions on quick-fix health trends.…
Charles · Mar 7, 2026Hims expansion may not come in time for risky GLP-1 business
Hims' expansion into the GLP-1 market is risky, with timing, regulation, and competition posing challenges. Can they succeed?
Charles · Mar 2, 2026Governing Biotechnology’s Dual-Use Security Dilemma
Exploring the dual-use dilemma in biotechnology, challenges in governance, and the role of technology in ensuring global security.
Charles · Feb 22, 2026Patients Who Don’t Want to Stop GLP-1s
Exploring the ethical challenges of prolonged GLP-1 usage in patients who fear discontinuation and the responsibilities of healthcare…
Charles · Feb 21, 2026Biotech Leader Joins Novo Nordisk Foundation as VP
A global biotechnology leader joins Novo Nordisk Foundation as VP, signaling new opportunities for innovation and sustainability in…
Charles · Feb 19, 2026CDC issues travel alert for Seychelles due to chikungunya
CDC issues travel alert for Seychelles due to chikungunya outbreak, advising travelers on precautions to ensure safety.
Charles · Feb 12, 2026How to help a snakebite victim? Doctors explain
How to help a snakebite victim? Doctors explain
Charles · Sep 23, 2025